BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22172433)

  • 1. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
    White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
    Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone for low libido in postmenopausal women not taking estrogen.
    Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
    N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Davis SR; Braunstein GD
    J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
    Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA; Simon JA; Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
    Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
    Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.
    White WB; Bakris GL; Bergenstal RM; Cannon CP; Cushman WC; Fleck P; Heller S; Mehta C; Nissen SE; Perez A; Wilson C; Zannad F
    Am Heart J; 2011 Oct; 162(4):620-626.e1. PubMed ID: 21982652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities.
    White WB; Chohan S; Dabholkar A; Hunt B; Jackson R
    Am Heart J; 2012 Jul; 164(1):14-20. PubMed ID: 22795277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
    Nathorst-Böös J; Flöter A; Jarkander-Rolff M; Carlström K; Schoultz Bv
    Maturitas; 2006 Jan; 53(1):11-8. PubMed ID: 16183220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approved hormonal treatments for HSDD: an unmet medical need.
    Snabes MC; Simes SM
    J Sex Med; 2009 Jul; 6(7):1846-9. PubMed ID: 19453872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
    El-Hage G; Eden JA; Manga RZ
    Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.
    Panay N; Al-Azzawi F; Bouchard C; Davis SR; Eden J; Lodhi I; Rees M; Rodenberg CA; Rymer J; Schwenkhagen A; Sturdee DW
    Climacteric; 2010 Apr; 13(2):121-31. PubMed ID: 20166859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.